CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy

Name: CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy
License: Public Domain

Shanghai Tongji Hospital, Tongji University School of Medicine

ClinicalTrials.gov · Datasets · License: Public Domain

leukemia, lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 290970
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.